The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multidisciplinary toxicity team for cancer immunotherapy-related adverse events.
 
Jarushka Naidoo
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Takeda
Research Funding - AstraZeneca (Inst); Calithera Biosciences (Inst); Kyowa Hakko Kirin (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Laura Cappelli
Research Funding - Bristol-Myers Squibb
 
Evan J. Lipson
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Sysmex (Inst)
Patents, Royalties, Other Intellectual Property - METHOD OF PREVENTING ORGAN TRANSPLANT REJECTIONS USING AGONISTS TO THE PD-1 CHECKPOINT PATHWAY (Inst)
 
Patrick M. Forde
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Celgene
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Kyowa Hakko Kirin (Inst); Novartis (Inst)
 
William Howard Sharfman
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb (Inst)
 
Jiajia Zhang
No Relationships to Disclose
 
Jenna Mammen
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson
 
Kendall Moseley
No Relationships to Disclose
 
Karthik Suresh
No Relationships to Disclose
 
Seema Mehta
No Relationships to Disclose
 
Inbal Sander
No Relationships to Disclose
 
John Probasco
No Relationships to Disclose
 
Alyssa Parian
No Relationships to Disclose
 
Rosanne Rouf
No Relationships to Disclose
 
Meghan Berkenstock
No Relationships to Disclose
 
Patricia Brothers
No Relationships to Disclose
 
Joanne Riemer
No Relationships to Disclose
 
Leisha A. Emens
Employment - FDA; Johns Hopkins University School of Medicine
Leadership - Society for Immunotherapy of Cancer
Stock and Other Ownership Interests - Molecuvax
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; etheRNA; Gritstone Bio; Medimmune; Molecuvax; Peregrine Pharmaceuticals; Replimune; Syndax
Research Funding - Aduro Biotech; AstraZeneca; Corvus Pharmaceuticals; EMD Serono; Genentech; Maxcyte; Merck; Roche
Other Relationship - Aduro Biotech
 
Clifton O. Bingham
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck